385P - Interim pharmacokinetic (PK) and pharmacodynamic (PD) data from the first-in-human study of NUC-3373, a pyrimidine nucleotide analogue, in patients with advanced solid tumors

Autor: Ghazaly, E. 1, Woodcock, V.K. 2, Spilipoulou, P. 3, Spiers, L. 2, Moschandreas, J. 4, Griffiths, L. 2, Gnanaranjan, C. 1, Harrison, D.J. 5, Evans, T.R.J. 3, Blagden, S.P. 2
Zdroj: In Annals of Oncology September 2017 28 Supplement 5:v128-v128
Databáze: ScienceDirect